PROFUND ADVISORS LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 208 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
PROFUND ADVISORS LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$221,416
-3.3%
3,010
+103.0%
0.01%
+100.0%
Q4 2021$229,000
-0.4%
1,483
-10.1%
0.01%
-12.5%
Q3 2021$230,000
+13.3%
1,650
+24.1%
0.01%0.0%
Q1 2021$203,000
-74.5%
1,330
-81.0%
0.01%
-78.9%
Q2 2019$797,000
-16.7%
6,984
-8.3%
0.04%
-17.4%
Q1 2019$957,000
+0.8%
7,614
+8.9%
0.05%
-22.0%
Q4 2018$949,000
-68.0%
6,990
-35.4%
0.06%
-47.8%
Q3 2018$2,970,000
+32.1%
10,821
-0.3%
0.11%
+25.6%
Q2 2018$2,248,000
+27.4%
10,852
+1.6%
0.09%
+28.6%
Q1 2018$1,765,000
+28.7%
10,685
+6.7%
0.07%
+32.1%
Q4 2017$1,371,000
-8.2%
10,015
-8.7%
0.05%
-14.5%
Q3 2017$1,493,000
+19.5%
10,966
+6.6%
0.06%
+8.8%
Q2 2017$1,249,000
+14.6%
10,289
-0.1%
0.06%
+16.3%
Q1 2017$1,090,000
-4.6%
10,300
-8.4%
0.05%
-7.5%
Q4 2016$1,143,000
-6.1%
11,245
-5.7%
0.05%
-8.6%
Q3 2016$1,217,000
+424.6%
11,922
+513.0%
0.06%
+427.3%
Q2 2016$232,000
+5.5%
1,945
-5.1%
0.01%0.0%
Q1 2016$220,000
-30.4%
2,050
-29.6%
0.01%
-26.7%
Q4 2015$316,000
-10.7%
2,910
-17.0%
0.02%0.0%
Q2 2015$354,000
-17.5%
3,505
-37.0%
0.02%
-11.8%
Q1 2015$429,000
+30.4%
5,560
+5.2%
0.02%
+21.4%
Q2 2014$329,000
+36.5%
5,284
+47.7%
0.01%
+27.3%
Q1 2014$241,000
-24.9%
3,577
-41.3%
0.01%
-21.4%
Q4 2013$321,0006,0970.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
BVF INC/IL 2,626,160$138,136,00024.17%
KNOTT DAVID M 1,292,566$67,988,972,00013.87%
GROW Partners, LLC 200,000$10,520,0006.41%
Opaleye Management Inc. 90,000$4,860,000,0003.82%
OBERWEIS ASSET MANAGEMENT INC/ 213,317$11,220,0002.72%
First Light Asset Management, LLC 60,242$3,169,0002.69%
Timpani Capital Management LLC 98,956$5,205,0002.59%
Iguana Healthcare Management, LLC 75,000$3,945,0002.25%
Eventide Asset Management 134,400$7,069,0002.18%
ASHFORD CAPITAL MANAGEMENT INC 215,223$11,321,0002.16%
View complete list of LIGAND PHARMACEUTICALS INC shareholders